Envestnet Asset Management Inc Bridge Bio Pharma, Inc. Transaction History
Envestnet Asset Management Inc
- $326 Billion
- Q2 2025
A detailed history of Envestnet Asset Management Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 39,487 shares of BBIO stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,487
Previous 12,987
204.05%
Holding current value
$2.17 Million
Previous $448,000
280.58%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BBIO
# of Institutions
410Shares Held
187MCall Options Held
11.3MPut Options Held
1.91M-
Viking Global Investors LP18.6MShares$1.02 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$907 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$730 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$685 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$510 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.16B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...